797 related articles for article (PubMed ID: 16139256)
1. Monitoring tryptophan metabolism in chronic immune activation.
Schröcksnadel K; Wirleitner B; Winkler C; Fuchs D
Clin Chim Acta; 2006 Feb; 364(1-2):82-90. PubMed ID: 16139256
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects.
Wirleitner B; Neurauter G; Schröcksnadel K; Frick B; Fuchs D
Curr Med Chem; 2003 Aug; 10(16):1581-91. PubMed ID: 12871129
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan degradation in patients with gynecological cancer correlates with immune activation.
Schroecksnadel K; Winkler C; Fuith LC; Fuchs D
Cancer Lett; 2005 Jun; 223(2):323-9. PubMed ID: 15896467
[TBL] [Abstract][Full Text] [Related]
4. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
6. Association between increased tryptophan degradation and depression in cancer patients.
Kurz K; Schroecksnadel S; Weiss G; Fuchs D
Curr Opin Clin Nutr Metab Care; 2011 Jan; 14(1):49-56. PubMed ID: 21076293
[TBL] [Abstract][Full Text] [Related]
7. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age.
Frick B; Schroecksnadel K; Neurauter G; Leblhuber F; Fuchs D
Clin Biochem; 2004 Aug; 37(8):684-7. PubMed ID: 15302611
[TBL] [Abstract][Full Text] [Related]
8. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan metabolism in chronic inflammatory lung disease.
Meyer KC; Arend RA; Kalayoglu MV; Rosenthal NS; Byrne GI; Brown RR
J Lab Clin Med; 1995 Dec; 126(6):530-40. PubMed ID: 7490512
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of immune activation using biochemical changes in a porcine model of cardiac arrest.
Amann A; Widner B; Rieder J; Antretter H; Hoffmann G; Mayr V; Strohmenger HU; Fuchs D
Mediators Inflamm; 2001 Dec; 10(6):343-6. PubMed ID: 11817676
[TBL] [Abstract][Full Text] [Related]
11. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
Zamanakou M; Germenis AE; Karanikas V
Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
[TBL] [Abstract][Full Text] [Related]
12. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan metabolism along the kynurenine pathway in diet-induced and genetic hypercholesterolemic rabbits.
Allegri G; Ragazzi E; Costa CV; Caparrotta L; Biasiolo M; Comai S; Bertazzo A
Clin Chim Acta; 2004 Dec; 350(1-2):41-9. PubMed ID: 15530458
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
[TBL] [Abstract][Full Text] [Related]
15. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
Oxenkrug GF
Ann N Y Acad Sci; 2007 Dec; 1122():35-49. PubMed ID: 18077563
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.
Rafice SA; Chauhan N; Efimov I; Basran J; Raven EL
Biochem Soc Trans; 2009 Apr; 37(Pt 2):408-12. PubMed ID: 19290871
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase.
Schmidt SK; Müller A; Heseler K; Woite C; Spekker K; MacKenzie CR; Däubener W
Eur J Immunol; 2009 Oct; 39(10):2755-64. PubMed ID: 19637229
[TBL] [Abstract][Full Text] [Related]
18. Neopterin production, tryptophan degradation, and mental depression--what is the link?
Widner B; Laich A; Sperner-Unterweger B; Ledochowski M; Fuchs D
Brain Behav Immun; 2002 Oct; 16(5):590-5. PubMed ID: 12401473
[TBL] [Abstract][Full Text] [Related]
19. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.
López AS; Alegre E; LeMaoult J; Carosella E; González A
Mol Immunol; 2006 Jul; 43(14):2151-60. PubMed ID: 16490253
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.
Ploder M; Spittler A; Schroecksnadel K; Neurauter G; Pelinka LE; Roth E; Fuchs D
Clin Sci (Lond); 2009 Apr; 116(7):593-8. PubMed ID: 18986303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
